These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17261311)

  • 1. Hydrostatic pressure influences morphology and expression of VE-cadherin of vascular endothelial cells.
    Ohashi T; Sugaya Y; Sakamoto N; Sato M
    J Biomech; 2007; 40(11):2399-405. PubMed ID: 17261311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biorheological views of endothelial cell responses to mechanical stimuli.
    Sato M; Ohashi T
    Biorheology; 2005; 42(6):421-41. PubMed ID: 16369082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VE-cadherin increases the half-life of VEGF receptor 2.
    Calera MR; Venkatakrishnan A; Kazlauskas A
    Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen tension modulates Ca2+ response to flow stimulus in endothelial cells exposed to hydrostatic pressure.
    Ohashi T; Sakamoto N; Iwao A; Sato M
    Technol Health Care; 2003; 11(4):263-74. PubMed ID: 14600337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells.
    Blecharz KG; Drenckhahn D; Förster CY
    J Cereb Blood Flow Metab; 2008 Jun; 28(6):1139-49. PubMed ID: 18231113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
    Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
    Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flow patterns on the localization and expression of VE-cadherin at vascular endothelial cell junctions: in vivo and in vitro investigations.
    Miao H; Hu YL; Shiu YT; Yuan S; Zhao Y; Kaunas R; Wang Y; Jin G; Usami S; Chien S
    J Vasc Res; 2005; 42(1):77-89. PubMed ID: 15637443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.
    Boda-Heggemann J; Régnier-Vigouroux A; Franke WW
    Cell Tissue Res; 2009 Jan; 335(1):49-65. PubMed ID: 19002500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
    Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
    Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
    Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
    Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway.
    Bieri M; Oroszlan M; Zuppinger C; Mohacsi PJ
    Mol Immunol; 2009 Feb; 46(5):866-72. PubMed ID: 18990449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
    Zhang Y; Gu Y; Lucas MJ; Wang Y
    J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial VE-cadherin expression in human lungs.
    Herwig MC; Müller KM; Müller AM
    Pathol Res Pract; 2008; 204(10):725-30. PubMed ID: 18639387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial (VE)-cadherin: only an intercellular glue?
    Dejana E; Bazzoni G; Lampugnani MG
    Exp Cell Res; 1999 Oct; 252(1):13-9. PubMed ID: 10502395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.
    Le Bras A; Lionneton F; Mattot V; Lelièvre E; Caetano B; Spruyt N; Soncin F
    Oncogene; 2007 Nov; 26(53):7480-9. PubMed ID: 17563748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
    Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
    Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension.
    Nelson CM; Chen CS
    J Cell Sci; 2003 Sep; 116(Pt 17):3571-81. PubMed ID: 12876221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cadherins and tumor angiogenesis.
    Cavallaro U; Liebner S; Dejana E
    Exp Cell Res; 2006 Mar; 312(5):659-67. PubMed ID: 16256984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmalemmal concentration and affinity of mouse vascular endothelial cadherin, VE-cadherin.
    Baumgartner W; Drenckhahn D
    Eur Biophys J; 2002 Dec; 31(7):532-8. PubMed ID: 12451422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.